COURTNEY OLOUGHLIN: Open Payments
NPI 1124743125 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,945 in 73 payments from 19 companies in 2025. Trend: 2023 $257 · 2024 $969 · 2025 $1,945
Food & beverage: $1,765Education: $180
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $433 |
| Novartis Pharmaceuticals Corporation | 15 | $334 |
| ABBVIE INC. | 16 | $268 |
| Regeneron Healthcare Solutions, Inc. | 5 | $218 |
| Botanix SB Inc | 2 | $121 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $95 |
| Incyte Corporation | 4 | $74 |
| Organon LLC | 3 | $63 |
| UCB, Inc. | 2 | $61 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $50 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, COSENTYX, SOFDRA, ILUMYA, OPZELURA, RINVOQ.
Industry payments across FL — which companies pay providers there.
